587 related articles for article (PubMed ID: 17234455)
1. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
Méndez A; Wägli F; Schmid I; Frey BM
Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
[TBL] [Abstract][Full Text] [Related]
2. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
[TBL] [Abstract][Full Text] [Related]
3. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
Tondon R; Pandey P; Chaudhry R
J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
[TBL] [Abstract][Full Text] [Related]
4. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
Katz L; Palmer K; McDonnell E; Kabat A
Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
[TBL] [Abstract][Full Text] [Related]
5. International variation in volunteer whole blood donor eligibility criteria.
Karp JK; King KE
Transfusion; 2010 Feb; 50(2):507-13. PubMed ID: 19788512
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
Enein AA; Hussein EA; El Shafie S; Hallouda M
J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
[TBL] [Abstract][Full Text] [Related]
7. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
[TBL] [Abstract][Full Text] [Related]
8. Selection of whole-blood donors for hemoglobin testing by use of historical hemoglobin values.
Ziemann M; Steppat D; Brockmann C; Washington G; Kirchner H; Schlenke P
Transfusion; 2006 Dec; 46(12):2176-83. PubMed ID: 17176332
[TBL] [Abstract][Full Text] [Related]
9. Switching iron-deficient whole blood donors to plateletpheresis.
O'Meara A; Infanti L; Sigle J; Stern M; Buser A
Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
[TBL] [Abstract][Full Text] [Related]
10. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
Fontana S; Mordasini L; Keller P; Taleghani BM
Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
[TBL] [Abstract][Full Text] [Related]
11. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
Zeiler T; Gritzka D; Karger R; Kretschmer V
Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
[TBL] [Abstract][Full Text] [Related]
12. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.
Garner SF; Jones CI; Stephens J; Burns P; Walton J; Bernard A; Angenent W; Ouwehand WH; Goodall AH;
Transfusion; 2008 Apr; 48(4):673-80. PubMed ID: 18194381
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
[TBL] [Abstract][Full Text] [Related]
14. A noninvasive strategy for screening prospective blood donors for anemia.
Lotfi R; Wernet D; Starke U; Northoff H; Cassens U
Transfusion; 2005 Oct; 45(10):1585-92. PubMed ID: 16181209
[TBL] [Abstract][Full Text] [Related]
15. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
Picker SM; Radojska SM; Gathof BS
Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
[TBL] [Abstract][Full Text] [Related]
17. Effect of increasing hemoglobin cutoff in male donors and increasing interdonation interval in whole blood donors at a hospital-based blood donor center.
Gandhi MJ; Duffy K; Benike M; Jenkins S; Stubbs JR
Transfusion; 2012 Sep; 52(9):1880-8. PubMed ID: 22313024
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
[TBL] [Abstract][Full Text] [Related]
19. High incidence of defective high-shear platelet function among platelet donors.
Harrison P; Segal H; Furtado C; Verjee S; Sukhu K; Murphy MF
Transfusion; 2004 May; 44(5):764-70. PubMed ID: 15104660
[TBL] [Abstract][Full Text] [Related]
20. Effects of high-yield thrombocytapheresis on the quality of platelet products.
Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
